Leaderboard

En | De
Sie sind hier: Onkologie 21. August 2026
Suchen
medline.ch
Onkologie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 98282  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 1965639  
   
Clinical management of adverse events in patients with advanced HER2+ metastatic breast cancer treated with tucatinib, trastuzumab, and capecitabine.
Oncologist
Okines AFC, Roesch E, Watkins K, Pitner MK, Hutchinson KM, Simon S, Yan F.
PMID: 42627360 [PubMed - as supplied by publisher]


Outcomes That Matter in Gastrointestinal Cancer Care: A Focus Group Study of Patient-Centred Outcomes Identified by Patients and Care Partners.
Health Expect
Gombay A, Ding A, Mahar A, Hsu AT, Gotlib Conn L, Armah J, Kosyachkova E, Deleemans J, Ludwig C, Karim A, Coburn N, Hallet J.
PMID: 42627289 [PubMed - indexed for MEDLINE]


Treatment Initiation of Definitive Radiotherapy in Patients With Locally Advanced Head and Neck Cancer.
Cancer Control
Guo LF, Lin LM, Lu ZZ, Hong ZC, Wu SG.
PMID: 42627284 [PubMed - indexed for MEDLINE]


Minimal intervention approach for a lesion suggestive of congenital granular cell epulis: a case report.
Gen Dent
Fitpaldi LMPT, Ataide DSM, Ionta FQ, Debortolli ALB, Caracho RA, Rios D.
PMID: 42627282 [PubMed - indexed for MEDLINE]


Clinicopathologic features and treatment outcomes of marginal gingival (ring around the collar) leukoplakia: a systematic review of emerging evidence.
Gen Dent
Ferraz DLF, Santos BC, Pedroso CM, Santos-Silva AR, Lopes MA.
PMID: 42627275 [PubMed - indexed for MEDLINE]


Feasibility and cost of partnering with social media influencers to promote colorectal cancer screening.
Health Educ Res
Orom H, Allard NC, Nguyen T.
PMID: 42627202 [PubMed - indexed for MEDLINE]


Beyond tissue biopsy: ctDNA methylation analysis for prediction of colorectal cancer prognosis.
Epigenomics
Irie T, Sugimoto K.
PMID: 42627151 [PubMed - as supplied by publisher]


Lung Cancer Screening Access and Cancer Stage at Diagnosis Among American Indian and White Patients.
J Rural Health
Jackson BE, Uhrin M, Wheeler SB, Baggett CD, Spees LP, Begay JA, Bell RA, Emerson MA.
PMID: 42627130 [PubMed - indexed for MEDLINE]


AI Model Predicts Cancer Development, Diagnoses Tumors.
Cancer Discov

PMID: 42627109 [PubMed - as supplied by publisher]


Collagen turnover biomarkers as diagnostic, prognostic, and therapy monitoring indicators in gastric cancer.
Cancer Biomark
Kaps L, Genc MA, Möhler M, Grabbe S, Sadiq SC, Schattenberg JM, Schuppan D, Pedersen RS, Karsdal MA, Mildenberger P, Maderer A, Willumsen N.
PMID: 42627091 [PubMed - indexed for MEDLINE]


Redox biology in PCOS: Biomarkers, mechanistic networks, and targeted interventions (Review).
Int J Mol Med
Qiu Y, Guo X, An J.
PMID: 42627082 [PubMed - indexed for MEDLINE]


Molecular classification and precision therapy in gastric cancer: Current advances and future perspectives (Review).
Oncol Rep
Xia S, Zhang X, Tang L, Li A, Chen J, Tao Z.
PMID: 42627081 [PubMed - indexed for MEDLINE]


Integrating Serum Lipid Biomarkers Into Machine Learning for the Differential Diagnosis of Breast Nodules.
Breast J
Chen L, Du Y, Liu W.
PMID: 42627076 [PubMed - indexed for MEDLINE]


Autophagy: Mechanisms and therapeutic perspectives in intestinal metaplasia (Review).
Mol Med Rep
Wu L, Liao L, Xia Z, Zeng Q, Huang A, Cao Z.
PMID: 42627075 [PubMed - indexed for MEDLINE]


Unlocking the potential of microRNA as predictive biomarkers for efficacy and adverse events in immune checkpoint inhibitor therapy (Review).
Mol Med Rep
Wang X, Duan B, Bai J, Liu H.
PMID: 42627073 [PubMed - indexed for MEDLINE]


Post‑translational modification‑governed immune states in cancer immunity: Biomarker implications for checkpoint competence, tumor visibility and immunotherapy resistance (Review).
Int J Oncol
Pan J, Li B, Lin R, Fang C, Lau LY, Hong Z, Chen Y.
PMID: 42627072 [PubMed - indexed for MEDLINE]


Immune Checkpoint Inhibitors in Advanced Sebaceous Carcinoma: A Systematic Review, Biomarker Analysis, and Clinical Recommendations.
J Cutan Med Surg
Abdul-Rahman NH, Joerg L, Gill C, Borda LJ, Thompson KG, Agarwal P, Choudhary S, Pugliano-Mauro MA.
PMID: 42627017 [PubMed - as supplied by publisher]


Natural Photosensitizers in Cancer Therapy: A Chemo-Biodiversity Perspective on Light-Activated Natural Compounds.
Chem Biodivers
Baidoo I, Abrahamse H, George BP.
PMID: 42626979 [PubMed - indexed for MEDLINE]


Inflammatory markers and the systemic immune-inflammation index in endometrial carcinoma and hyperplasia: a retrospective cohort study.
J Obstet Gynaecol
Atalay F, Atalay CR, Zorlu U, Arslanca T.
PMID: 42626923 [PubMed - indexed for MEDLINE]


Planning and Sustaining Breast Cancer Patient Navigation Programs: A CFIR-Informed Scoping Review of Implementation Determinants.
Int J Health Plann Manage
Saharudin SN, Hassan NMA, Fauzi MFF, Sha'ari AZ, Ghazali MFM, Rahim AIA.
PMID: 42626898 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 1965639    Seite 1 von 98282  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1